1 Market Overview
1.1 Gastrointestinal Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastrointestinal Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastrointestinal Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Global Gastrointestinal Drugs Market Size & Forecast
1.4.1 Global Gastrointestinal Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gastrointestinal Drugs Sales in Volume (2017-2028)
1.4.3 Global Gastrointestinal Drugs Price (2017-2028)
1.5 Global Gastrointestinal Drugs Production Capacity Analysis
1.5.1 Global Gastrointestinal Drugs Total Production Capacity (2017-2028)
1.5.2 Global Gastrointestinal Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastrointestinal Drugs Market Drivers
1.6.2 Gastrointestinal Drugs Market Restraints
1.6.3 Gastrointestinal Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Gastrointestinal Drugs Product and Services
2.1.4 AstraZeneca Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Gastrointestinal Drugs Product and Services
2.2.4 Sanofi Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Gastrointestinal Drugs Product and Services
2.3.4 Bayer Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Gastrointestinal Drugs Product and Services
2.4.4 Pfizer Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Gastrointestinal Drugs Product and Services
2.5.4 GlaxoSmithKline Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Gastrointestinal Drugs Product and Services
2.6.4 Teva Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zeria (Tillotts)
2.7.1 Zeria (Tillotts) Details
2.7.2 Zeria (Tillotts) Major Business
2.7.3 Zeria (Tillotts) Gastrointestinal Drugs Product and Services
2.7.4 Zeria (Tillotts) Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Perrigo
2.8.1 Perrigo Details
2.8.2 Perrigo Major Business
2.8.3 Perrigo Gastrointestinal Drugs Product and Services
2.8.4 Perrigo Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Gastrointestinal Drugs Product and Services
2.9.4 Boehringer Ingelheim Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Purdue Pharma
2.10.1 Purdue Pharma Details
2.10.2 Purdue Pharma Major Business
2.10.3 Purdue Pharma Gastrointestinal Drugs Product and Services
2.10.4 Purdue Pharma Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 C.B. Fleet
2.11.1 C.B. Fleet Details
2.11.2 C.B. Fleet Major Business
2.11.3 C.B. Fleet Gastrointestinal Drugs Product and Services
2.11.4 C.B. Fleet Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Abbott
2.12.1 Abbott Details
2.12.2 Abbott Major Business
2.12.3 Abbott Gastrointestinal Drugs Product and Services
2.12.4 Abbott Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Jiangzhong
2.13.1 Jiangzhong Details
2.13.2 Jiangzhong Major Business
2.13.3 Jiangzhong Gastrointestinal Drugs Product and Services
2.13.4 Jiangzhong Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Xian-Janssen
2.14.1 Xian-Janssen Details
2.14.2 Xian-Janssen Major Business
2.14.3 Xian-Janssen Gastrointestinal Drugs Product and Services
2.14.4 Xian-Janssen Gastrointestinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gastrointestinal Drugs Breakdown Data by Manufacturer
3.1 Global Gastrointestinal Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gastrointestinal Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gastrointestinal Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Gastrointestinal Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Gastrointestinal Drugs Manufacturer Market Share in 2021
3.5 Global Gastrointestinal Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gastrointestinal Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gastrointestinal Drugs Market Size by Region
4.1.1 Global Gastrointestinal Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Gastrointestinal Drugs Revenue by Region (2017-2028)
4.2 North America Gastrointestinal Drugs Revenue (2017-2028)
4.3 Europe Gastrointestinal Drugs Revenue (2017-2028)
4.4 Asia-Pacific Gastrointestinal Drugs Revenue (2017-2028)
4.5 South America Gastrointestinal Drugs Revenue (2017-2028)
4.6 Middle East and Africa Gastrointestinal Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gastrointestinal Drugs Sales in Volume by Type (2017-2028)
5.2 Global Gastrointestinal Drugs Revenue by Type (2017-2028)
5.3 Global Gastrointestinal Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gastrointestinal Drugs Sales in Volume by Application (2017-2028)
6.2 Global Gastrointestinal Drugs Revenue by Application (2017-2028)
6.3 Global Gastrointestinal Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gastrointestinal Drugs Sales by Type (2017-2028)
7.2 North America Gastrointestinal Drugs Sales by Application (2017-2028)
7.3 North America Gastrointestinal Drugs Market Size by Country
7.3.1 North America Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Gastrointestinal Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gastrointestinal Drugs Sales by Type (2017-2028)
8.2 Europe Gastrointestinal Drugs Sales by Application (2017-2028)
8.3 Europe Gastrointestinal Drugs Market Size by Country
8.3.1 Europe Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Gastrointestinal Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gastrointestinal Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Gastrointestinal Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Gastrointestinal Drugs Market Size by Region
9.3.1 Asia-Pacific Gastrointestinal Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gastrointestinal Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gastrointestinal Drugs Sales by Type (2017-2028)
10.2 South America Gastrointestinal Drugs Sales by Application (2017-2028)
10.3 South America Gastrointestinal Drugs Market Size by Country
10.3.1 South America Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Gastrointestinal Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gastrointestinal Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Gastrointestinal Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Gastrointestinal Drugs Market Size by Country
11.3.1 Middle East & Africa Gastrointestinal Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gastrointestinal Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gastrointestinal Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gastrointestinal Drugs
12.3 Gastrointestinal Drugs Production Process
12.4 Gastrointestinal Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gastrointestinal Drugs Typical Distributors
13.3 Gastrointestinal Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界の胃腸薬市場2022年：市場規模予測（～2028年） |
| 【英語タイトル】Global Gastrointestinal Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22DC3808 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2023年1月 ・ページ数：102 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 胃腸薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の胃腸薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 胃腸薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・処方胃腸薬、OTC胃腸薬 用途別セグメントは次のように区分されます。 ・慢性胃炎、機能性ディスペプシア、消化性潰瘍、急性胃腸炎、その他 世界の胃腸薬市場の主要な市場プレーヤーは以下のとおりです。 ・AstraZeneca、Sanofi、Bayer、Pfizer、GlaxoSmithKline、Teva、Zeria (Tillotts)、Perrigo、Boehringer Ingelheim、Purdue Pharma、C.B. Fleet、Abbott、Jiangzhong、Xian-Janssen 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、胃腸薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な胃腸薬メーカーの企業概要、2019年～2022年までの胃腸薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な胃腸薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別胃腸薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの胃腸薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での胃腸薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および胃腸薬の産業チェーンを掲載しています。 ・第13、14、15章では、胃腸薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 胃腸薬の概要 - 種類別分析（2017年vs2021年vs2028年）：処方胃腸薬、OTC胃腸薬 - 用途別分析（2017年vs2021年vs2028年）：慢性胃炎、機能性ディスペプシア、消化性潰瘍、急性胃腸炎、その他 - 世界の胃腸薬市場規模・予測 - 世界の胃腸薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - AstraZeneca、Sanofi、Bayer、Pfizer、GlaxoSmithKline、Teva、Zeria (Tillotts)、Perrigo、Boehringer Ingelheim、Purdue Pharma、C.B. Fleet、Abbott、Jiangzhong、Xian-Janssen ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：処方胃腸薬、OTC胃腸薬 ・用途別分析2017年-2028年：慢性胃炎、機能性ディスペプシア、消化性潰瘍、急性胃腸炎、その他 ・胃腸薬の北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・胃腸薬のヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・胃腸薬のアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・胃腸薬の南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・胃腸薬の中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gastrointestinal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gastrointestinal Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Chronic Gastritis accounting for % of the Gastrointestinal Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prescription Gastrointestinal Drug segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gastrointestinal Drugs include AstraZeneca, Sanofi, Bayer, Pfizer, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gastrointestinal Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Market segment by Application can be divided into
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
The key market players for global Gastrointestinal Drugs market are listed below:
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastrointestinal Drugs, with price, sales, revenue and global market share of Gastrointestinal Drugs from 2019 to 2022.
Chapter 3, the Gastrointestinal Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gastrointestinal Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Drugs.
Chapter 13, 14, and 15, to describe Gastrointestinal Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
❖ レポートの目次 ❖
| ★調査レポート[世界の胃腸薬市場2022年：市場規模予測（～2028年）] (コード：GIR22DC3808)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の胃腸薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせ |
